This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Napco (NSSC) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Napco (NSSC) delivered earnings and revenue surprises of 64.29% and 8.63%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Napco (NSSC) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Napco (NSSC) delivered earnings and revenue surprises of 21.43% and 11%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Unifi (UFI) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Unifi (UFI) delivered earnings and revenue surprises of -4,300% and 6.94%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Is NAPCO Security Technologies (NSSC) Outperforming Other Industrial Products Stocks This Year?
by Zacks Equity Research
Here is how Napco (NSSC) and O-I Glass (OI) have performed compared to their sector so far this year.
Has NAPCO Security Technologies (NSSC) Outpaced Other Industrial Products Stocks This Year?
by Zacks Equity Research
Here is how Napco (NSSC) and O-I Glass (OI) have performed compared to their sector so far this year.
Zacks.com featured highlights include Terns Pharmaceuticals, Napco Security Technologies and AVEO
by Zacks Equity Research
Terns Pharmaceuticals, Napco Security Technologies and AVEO have been highlighted in this Screen of The Week article.
Fight Back Against Inflation with New Analyst Coverage
by Benjamin Rains
Check out this new analyst coverage screen to help investors find stocks that are gaining more attention from Wall Street analysts that could be potential winners in the fourth quarter of 2022 and beyond.
New Analysts Initiate Coverage: 3 Top-Ranked Stocks to Buy
by Shrabana Mukherjee
Increased analyst coverage over the past few weeks may lead to solid price appreciation for stocks like Terns Pharmaceuticals (TERN), Napco Security (NSSC) and AVEO.
Is Lindsay (LNN) Outperforming Other Industrial Products Stocks This Year?
by Zacks Equity Research
Here is how Lindsay (LNN) and Napco (NSSC) have performed compared to their sector so far this year.
5 Top Stocks to Buy on New Analysts' Coverage
by Shrabana Mukherjee
Increased analyst coverage over the past few weeks may lead to solid price appreciation for stocks like Napco Security (NSSC), Proto Labs (PRLB), Clear Secure (YOU), AVEO and Mind Medicine (MNMD).
3 Reasons Why Napco (NSSC) Is a Great Growth Stock
by Zacks Equity Research
Napco (NSSC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Has Lindsay (LNN) Outpaced Other Industrial Products Stocks This Year?
by Zacks Equity Research
Here is how Lindsay (LNN) and Napco (NSSC) have performed compared to their sector so far this year.
Napco (NSSC) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Napco (NSSC) delivered earnings and revenue surprises of 122.22% and 12.14%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Allegion (ALLE) Down 30.3% in a Year: What's Hurting it?
by Zacks Equity Research
Allegion (ALLE) is witnessing weakness across its residential business, owing to supply chain challenges, electronic chip shortages, rising costs and a high debt level.
Cintas (CTAS) Displays Bright Prospects, Headwinds Remain
by Zacks Equity Research
Cintas (CTAS) stands to benefit from strength across its businesses, focus on operational execution and shareholder-friendly policies. Rising costs and expenses along with high tax rate ail.
Reasons Why You Should Avoid Investing in Allegion (ALLE) Now
by Zacks Equity Research
Allegion (ALLE) experiences weakness across its residential business and bears a heavy tax load coupled with a high debt level.
Allegion (ALLE) Prices Senior Notes Offering Worth $600M
by Zacks Equity Research
Allegion (ALLE) prices senior notes worth $600 million in aggregate principal amount. The net proceeds will be used to finance the buyout of Stanley Access Technologies.
Is the Options Market Predicting a Spike in Napco (NSSC) Stock?
by Zacks Equity Research
Investors need to pay close attention to Napco (NSSC) stock based on the movements in the options market lately.
Napco (NSSC) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Napco (NSSC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Napco (NSSC) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Napco (NSSC) delivered earnings and revenue surprises of 100% and 4.41%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Avery Dennison (AVY) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Avery Dennison (AVY) delivered earnings and revenue surprises of 10.09% and 2.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Napco (NSSC) Lags Q2 Earnings Estimates
by Zacks Equity Research
Napco (NSSC) delivered earnings and revenue surprises of -66.67% and 6.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Napco (NSSC) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Napco (NSSC) delivered earnings and revenue surprises of 4.17% and 6.65%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Napco (NSSC) to Report Q1 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Napco (NSSC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for September 15th
by Zacks Equity Research
ARCE, NSSC, PAGP, TRIL, and VALE have been added to the Zacks Rank #5 (Strong Sell) List on September 15, 2021.